Synlogic, Inc. (SYBX) stock
SYBXOTCPharmaceutical PreparationsFiscal year ends December 31
$1.07+0.07 (+7.00%)
Close on Oct 19, 2026Market cap $13.29MP/E –Yield –
Synlogic free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Synlogic's free cash flow for the twelve months ending Dec 31, 2025 was -$4.36M. For fiscal 2025 it was -$4.36M. The highest annual figure on record is -$4.36M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.36M | – |
| FY2024 | Dec 31, 2024 | -$31.67M | – |
| FY2023 | Dec 31, 2023 | -$51.83M | – |
| FY2022 | Dec 31, 2022 | -$57.62M | – |
| FY2021 | Dec 31, 2021 | -$52.88M | – |
| FY2020 | Dec 31, 2020 | -$39.95M | – |
| FY2019 | Dec 31, 2019 | -$76.72M | – |
| FY2018 | Dec 31, 2018 | -$48.12M | – |
| FY2017 | Dec 31, 2017 | -$33.63M | – |
| FY2016 | Dec 31, 2016 | -$22.25M | – |
| FY2015 | Dec 31, 2015 | -$21.39M | – |
| FY2014 | Dec 31, 2014 | -$14.07M | – |
| FY2013 | Dec 31, 2013 | -$6.50M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$923.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.44M | – |
| Q2 FY2025 | Jun 30, 2025 | -$399.00K | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.60M | – |
| Q4 FY2024 | Dec 31, 2024 | -$568.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$648.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$14.63M | – |
| Q1 FY2024 | Mar 31, 2024 | -$15.83M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.56M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.96M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.67M | – |
| Q1 FY2023 | Mar 31, 2023 | -$21.65M | – |
| Q4 FY2022 | Dec 31, 2022 | -$12.44M | – |
| Q3 FY2022 | Sep 30, 2022 | -$15.51M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.72M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.95M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.23M | – |
| Q3 FY2021 | Sep 30, 2021 | -$14.20M | – |
| Q2 FY2021 | Jun 30, 2021 | -$11.45M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.00M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.90M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.26M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.04M | – |
| Q1 FY2020 | Mar 31, 2020 | -$12.75M | – |
| Q4 FY2019 | Dec 31, 2019 | -$11.62M | – |
| Q3 FY2019 | Sep 30, 2019 | -$10.70M | – |
| Q2 FY2019 | Jun 30, 2019 | -$41.02M | – |
| Q1 FY2019 | Mar 31, 2019 | -$13.38M | – |
| Q4 FY2018 | Dec 31, 2018 | -$10.36M | – |
| Q3 FY2018 | Sep 30, 2018 | -$11.03M | – |
| Q2 FY2018 | Jun 30, 2018 | -$11.79M | – |
| Q1 FY2018 | Mar 31, 2018 | -$14.94M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.07M | – |
| Q3 FY2017 | Sep 30, 2017 | -$9.61M | – |
| Q2 FY2017 | Jun 30, 2017 | -$7.93M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.03M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.67M | – |
See a number that looks wrong?